2020
DOI: 10.2147/dmso.s233078
|View full text |Cite
|
Sign up to set email alerts
|

<p>Hypoglycemia After Upper Gastrointestinal Surgery: Clinical Approach to Assessment, Diagnosis, and Treatment</p>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 106 publications
0
18
0
2
Order By: Relevance
“…Management and treatment may be aided by novel interventions, such as continuous glucose monitoring, which could be a useful tool in the diagnosis and management of reactive hypoglycaemia [96]. It may also facilitate strategies to reduce the impact of dumping on HRQL, especially social and cognitive function [97].…”
Section: Discussionmentioning
confidence: 99%
“…Management and treatment may be aided by novel interventions, such as continuous glucose monitoring, which could be a useful tool in the diagnosis and management of reactive hypoglycaemia [96]. It may also facilitate strategies to reduce the impact of dumping on HRQL, especially social and cognitive function [97].…”
Section: Discussionmentioning
confidence: 99%
“…In a stepwise manner, biochemical analysis must be performed to rule out other causes[ 18 ]. Plasma glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and cortisol levels should be measured.…”
Section: Discussionmentioning
confidence: 99%
“…Plasma glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and cortisol levels should be measured. The development of provocative studies such as a 72-h fasting test is also recommended[ 10 , 18 ]. The goal is to determine whether beta-cell peptides are appropriately suppressed during hypoglycemia.…”
Section: Discussionmentioning
confidence: 99%
“…Altered nutrient delivery is reported to be closely related to postprandial GLP-1 increase, which is upregulated over 10-fold after RGYB in symptomatic patients with post-bariatric hypoglycemia [47]. Elevated GLP-1, together with high glucose, leads to significant insulin release and subsequent rapid drop in plasma glucose levels after meals [46]. Intriguingly, GLP-1 receptor antagonist exendin (9-39) normalizes insulin secretion and prevents hypoglycemia during an oral glucose tolerance test in patients with confirmed post-bariatric hypoglycemia [26].…”
Section: The Mechanisms Of Hypoglycemiamentioning
confidence: 99%
“…Intestine-specific mechanisms may play an essential role in hypoglycemia [46]. Particularly, exaggerated secretion of GLP-1 is considered a critical factor [26].…”
Section: The Mechanisms Of Hypoglycemiamentioning
confidence: 99%